Tectonic Therapeutic Reports Q3 GAAP EPS of -$1.08, Exceeding Estimates
Tectonic Therapeutic (TECX) reported third-quarter GAAP earnings per share of -$1.08, which outperformed analyst expectations by $0.24. The company's financial position remains stable with cash and cash equivalents totaling $234.7 million as of September 30, 2026. This liquidity includes approximately $22.3 million in net proceeds from a recent at-the-market offering. Based on current holdings, management expects the company's cash runway to extend into the first quarter of 2029, providing significant operational buffer for ongoing development.
Tickers: $TECX